✷ Report Code: A02104 | Pages: 220 | ||
Tables: 89 | Charts: 57 |
|
The global vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030. A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting blood vessels. Vascular grafts are used for the surgery of vascular diseases. Vascular disease includes any condition that affects normal blood circulatory system, such as peripheral artery disease (PAD), abdominal aortic aneurysm (AAA), carotid artery disease (CAD), arteriovenous malformation (AVM), critical limb-threatening ischemia (CLTI), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins.
The growth of the global vascular grafts market is majorly driven by increase in vascular diseases, such as atherosclerosis, pulmonary embolism, deep vein thrombosis, and other cardiac disorders as well as increase in number of hospitals and surgery centers, which boost the diagnosis and treatment of diseases. For instance, according to the report of the American Heart Association, in 2019, 197.2 million people lived with ischemic heart disease (IHD). In addition, increase in cardiovascular disorders is one of the key drivers of the market. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019.
Moreover, advancements in vascular disease devices are anticipated to contribute toward the growth of the market. In addition, new product launches in market further boost the market growth. However, product failure and product recalls are expected to restrict the market growth during the forecast period.
The vascular graft market is segmented on the basis of product, raw material, and end users. By product, the market is mainly categorized into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular aneurysm repair stent grafts are further subcategorized into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). By raw material, it is categorized in polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. By end users, it is divided into hospitals and ambulatory surgical centers (ASCs).
By region, the vascular graft market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).
On the basis of product, the hemodialysis access graft segment dominated the vascular grafts market in 2020, and this trend is expected to continue during the forecast period, owing to increase in cardiovascular diseases. However, the endovascular aneurysm repair stent grafts segment is expected to witness considerable growth during the forecast period, owing to advancements in endovascular grafts therapy.
On the basis of raw material, the polyurethane segment was the major contributor in 2020 and is expected to maintain its lead during the forecast period, owing to reliability of polyester material. However, the inhaled biosynthetic segment is expected to witness considerable growth during the forecast period, due to development of advanced biosynthetic materials.
On the basis of end users, the hospitals segment was the major contributor in 2020 and is expected to maintain its lead during the forecast period, owing to increase in number of hospitals. However, the inhaled ambulatory surgical centers (ASCs) segment is expected to witness considerable growth during the forecast period, due to rise in number of ambulatory surgical centers.
On the basis of region, North America garnered the major share in the vascular graft market in 2020, and is expected to dominate the global market during the forecast period, owing to the rise in prevalence of cardiac diseases, presence of key players for manufacturing of vascular grafts, and well-established infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR of xx% from 2021 to 2030, owing to increase in the number of hospitals, increase in cardiac surgeries, and high population.
The key players operating in the global vascular graft market include B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation, and W. L. Gore & Associates, Inc.
Key Benefits For Stakeholders
Vascular Graft Market Report Highlights
Aspects | Details |
---|---|
By Product |
|
By Raw Material |
|
By End User |
|
By Region |
|
By Key Market Players |
|
Loading Table Of Content...
Vascular grafting is done to bypass a complete or partial blockage in an artery to improve blood flow to the organ supplied by the diseased artery.
The vascular grafts products include hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Hemodialysis access graft dominates the market owing to the increase in vascular diseases.
Factors such as increase in prevalence of cardiovascular diseases, rise in number of hospitals, and advancements in vascular surgeries drive the growth of market. In addition, initiatives taken by the government to treat vascular diseases are expected to drive the growth of the vascular grafts market.
North America is expected to witness the highest growth, in terms of revenue, owing to the rise in prevalence of vascular diseases, the presence of key players for manufacturing and developing of vascular grafts, and increase in number of hospitals and surgical centers, in the region.
However, the high cost associated with vascular surgeries and product failure are expected to hamper the market growth during the forecast period.
A. The total market value of vascular grafts market is $4993.64 million in 2020.
A. The forecast period in the report is from 2021 to 2030
A. The market value of vascular grafts market in 2021 was $5253.31 million
A. The base year for the report is 2020.
A. Yes, vascular grafts companies are profiled in the report
A. The top companies that hold the market share in vascular grafts market are B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation, and W. L. Gore & Associates, Inc.
A. Asia-Pacific is expected to register the highest CAGR of 4.87% from 2021 to 2030, owing to increase in number of hospitals, and prevalence of cardiac diseases.
A. The key trends in the vascular grafts market are by an increase in the prevalence of vascular diseases; rise in number of hospitals; and increase in healthcare expenditure of patients.
Start reading instantly.
This Report and over 71,321+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers